ELMS STEVE
SEC insider (Form 3/4/5 filer). CIK 0001250195. Director at ADMA BIOLOGICS, INC. (ADMA) and 2 other issuers. 28 reported Form 4/5 transactions since Sep 2024; latest on Mar 6, 2026. Located in NEW YORK, NY.
Companies ELMS STEVE has filed insider reports for
- ADMA BIOLOGICS, INC. (ADMA): Director
- Marker Therapeutics, Inc. (MRKR): Director
- Elevation Oncology, Inc. (ELEV): Director
ELMS STEVE
CIK: 0001250195
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Mar 6, 2026ADMA
ADMA BIOLOGICS, INC.
PurchaseIndirect7K shares at avg. $15.39$108K - Mar 5, 2026ADMA
ADMA BIOLOGICS, INC.
PurchaseIndirect7K shares at avg. $15.67$110K - Feb 9, 2026ADMA
ADMA BIOLOGICS, INC.
AwardDirect10.7K shares- - Nov 17, 2025MRKR
Marker Therapeutics, Inc.
AwardDirectStock Option (right to buy)
137.3K shares- - Nov 17, 2025MRKR
Marker Therapeutics, Inc.
AwardDirectStock Option (right to buy)
84.4K shares- - Jul 23, 2025ELEV
Elevation Oncology, Inc.
DispositionIndirectStock Option (Right to Buy)
15.6K shares- - Jul 23, 2025ELEV
Elevation Oncology, Inc.
DispositionIndirectStock Option (Right to Buy)
31.2K shares- - Jul 23, 2025ELEV
Elevation Oncology, Inc.
DispositionIndirectStock Option (Right to Buy)
31.2K shares- - Jul 23, 2025ELEV
Elevation Oncology, Inc.
DispositionIndirectStock Option (Right to Buy)
35K shares- - Jul 23, 2025ELEV
Elevation Oncology, Inc.
DispositionIndirectStock Option (Right to Buy)
35K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 6, 2026 |  ADMA ADMA BIOLOGICS, INC. | Purchase | 7,000 | $15.39 | $107,730 | Indirect |
| Mar 5, 2026 | ADMA ADMA BIOLOGICS, INC. | Purchase | 7,000 | $15.67 | $109,690 | Indirect |
| Feb 9, 2026 | ADMA ADMA BIOLOGICS, INC. | Award | 10,690 | - | $0 | Direct |
| Nov 17, 2025 |  MRKR Marker Therapeutics, Inc. | Award Stock Option (right to buy) | 137,330 | - | - | Direct |
| Nov 17, 2025 | MRKR Marker Therapeutics, Inc. | Award Stock Option (right to buy) | 84,411 | - | - | Direct |
| Jul 23, 2025 |  ELEV Elevation Oncology, Inc. | Disposition Stock Option (Right to Buy) | 15,619 | - | - | Indirect |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | Disposition Stock Option (Right to Buy) | 31,238 | - | - | Indirect |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | Disposition Stock Option (Right to Buy) | 31,238 | - | - | Indirect |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | Disposition Stock Option (Right to Buy) | 35,000 | - | - | Indirect |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | Disposition Stock Option (Right to Buy) | 35,000 | - | - | Indirect |
1-10 of 28 transactions